Results 151 to 160 of about 9,994 (168)

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer’s disease

Biological Psychiatry, 2001
Joseph Coyle, Paul Kershaw
exaly  

Galantamine

Reactions Weekly, 2014
openaire   +1 more source

Galantamine

Reactions Weekly
openaire   +2 more sources

Steady-State Pharmacokinetics of Galantamine Are Not Affected by Addition of Memantine in Healthy Subjects

Journal of Clinical Pharmacology, 2005
Jeffrey Nye
exaly  

Galantamine

Reactions Weekly, 2005
openaire   +1 more source

Galantamine Extended Release

CNS Drugs, 2012
Dean Robinson, Robinson Dean M, Plosker Greg L   +2 more
exaly  

Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease

International Journal of Geriatric Psychiatry, 2001
exaly  

Galantamine

2016
openaire   +1 more source

Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons

Neuroscience Letters, 2003
Xiaoliang Wang
exaly  

PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD

Neurobiology of Aging, 2008
Anna Ringheim, Taher Darreh-Shori
exaly